Morning Overview on MSN
New combination therapy achieves unprecedented remission in glioblastoma brain cancer models
Glioblastoma is the most aggressive primary brain cancer in adults, killing most patients within two years of diagnosis ...
An artificial intelligence model from the Mayo Clinic detected abnormalities on scans up to two years before patients were ...
Researchers at Trinity College Dublin have published a major new review that brings fresh clarity to one of the deadliest ...
Pancreatic ductal adenocarcinoma is one of the deadliest cancer types, with a five-year survival rate of 13%. There are only ...
Researchers at the University of Illinois Chicago have developed an anti-cancer therapy inspired by bacteria found in cancer ...
At AACR 2026, scientists showcased advances in radiotherapeutics, antibody-drug conjugates, T cell engagers, and ...
Health care policy researcher Nancy Keating discusses two new studies that suggest the short-lived experiment was more ...
At AACR 2026, researchers discussed the promise and challenges of bringing AI-powered tools into cancer research and clinical ...
AACR 2026 saw thousands gathered in San Diego, California, where major progress in cancer research was revealed.
Researchers at AACR shared data on their model's ability to predict which NSCLC patients are likely to respond to ...
Data showcase advances across oncology pipeline including pan-mutant BRAF, CBL-B and AURKA programsPresentations reinforce potential of degraders ...
There are a number of AI-based approaches that have shown potential in recent years, but Path-IO really stands apart because ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results